FDA.reportPublic FDA data

taletrectinib 200 MG Oral Capsule

RxCUI
2716925
RxNorm name
taletrectinib 200 MG Oral Capsule
Display name
taletrectinib 200 MG Oral Capsule
Full name
taletrectinib 200 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
51ac8e52-3269-4102-8dc8-dba22d82128ctaletrectinib 200 MG Oral Capsule [PSN] · taletrectinib 200 MG Oral Capsule [SCD] · taletrectinib 200 MG (as taletrectinib adipate 272 MG) Oral Capsule [SY]34These highlights do not include all the information needed to use IBTROZI safely and effectively. See full prescribing information for IBTROZI. IBTROZI ® (taletrectinib) capsules, for oral use Initial U.S. Approval: 202520260323